Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James Edgemond currently holds 9,018 shares of UNITED THERAPEUTICS Corp (UTHR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James Edgemond has been a net seller of UTHR stock. They have purchased $0 and sold $87.5M worth of shares.
James Edgemond's most recent insider trade was on Dec 15, 2025, when they sold 200 shares at $496.97 per share.
James Edgemond serves as Executive at UNITED THERAPEUTICS Corp (UTHR). They have executed 188 insider transactions totaling $87.5M over their tenure at the company.
James Edgemond holds the position of Executive at UNITED THERAPEUTICS Corp, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
James Edgemond has shown a selling trading pattern, with $0 in total purchases and $87.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by James Edgemond was on Dec 1, 2025, when they sold $3.6M worth of UTHR shares. This transaction involved 7,552 shares at $479.92 per share.
James Edgemond currently owns 9,018 shares of UNITED THERAPEUTICS Corp (UTHR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James Edgemond's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James Edgemond has 188 Form 4 filings on record as an insider at UNITED THERAPEUTICS Corp.
Set alerts for James Edgemond and 40,000+ other insiders.